What Researchers Did
Researchers investigated if hyperbaric oxygen therapy (HBOT) could improve insulin sensitivity and stroke recovery in 52 patients with type 2 diabetes who had experienced a brain bleed.
What They Found
After HBOT, patients showed a 37.8% increase in their glucose infusion rate after one month, indicating improved insulin sensitivity. They also had lower levels of serum insulin, fasting glucose, and hemoglobin A1C. The HBOT group showed significant improvements in stroke recovery scores (NIHSS) at both 10 days and one month compared to baseline and the control group.
What This Means for Canadian Patients
For Canadian patients with type 2 diabetes who suffer a brain bleed, HBOT might help improve how their body handles sugar and aid in their recovery from the stroke. This could potentially lead to better long-term health outcomes by addressing both their diabetes and neurological injury.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study involved a relatively small number of participants from a single hospital, which may limit how broadly these findings can be applied.